In ref. [25], authors designed a multiparameter lead generation workflow aimed at identifying optimal core structures for BACE-1 inhibitors as potential treatments for Alzheimer’s disease. Here, BACE1 is linked to early-onset autosomal dominant Alzheimer disease.